Novel Immune Checkpoints in Esophageal Cancer: From Biomarkers to Therapeutic Targets
Esophageal cancer ranks as the sixth most common Dice cause of cancer death worldwide.Due to the limited efficacy of conventional therapeutic strategies, including surgery, chemotherapy, and radiotherapy, treatments are still far from satisfactory in terms of survival, prompting the search for novel treatment methods.Immune checkpoints play crucial